MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
0.48%
Quick Ratio
0.48%
Cash Ratio
0.35%
Unit: Dollar
Assets Breakdown
    • Cash and cash equivalents
    • Prepaid expenses and other recei...
    • Equipment, net
Liabilities Breakdown
    • Accumulated deficit
    • Additional paid-in capital
    • Due to a related party
    • Others
Balance Sheets
2026-05-31
2026-02-28
2025-11-30
2025-08-31
Cash and cash equivalents
9,487
12,154
7,703
15,111
Prepaid expenses and other receivables
3,308
2,745
3,459
3,326
Total current assets
12,795
14,899
11,162
18,437
Equipment, net
0
0
0
0
Total assets
12,795
14,899
11,162
18,437
Accounts payable and accrued liabilities
45,228
43,530
45,631
49,252
Convertible loan
1,047,204
1,090,370
1,206,512
1,197,257
Short term loan
120,000
75,000
40,000
-
Due to a related party
1,460,077
1,339,547
1,291,990
1,268,221
Total current liabilities
2,672,509
2,548,447
2,584,133
2,514,730
Common stock, 0.0001 par value, 1,800,000,000 shares authorized, 1,475,768,095 and 553,962,206 shares issued and outstanding at may 31, 2026 and august 31, 2025, respectively
147,576
112,577
75,319
55,396
Additional paid-in capital
22,773,068
22,780,068
22,733,805
22,716,687
Issuance of warrants
0
0
-
-
Other comprehensive loss
0
0
-
-
Accumulated deficit
-25,580,358
-25,426,193
-25,382,095
-25,268,376
Total stockholders' equity (deficit)
-2,659,714
-2,533,548
-2,572,971
-2,496,293
Total liabilities and stockholders' equity
12,795
14,899
11,162
18,437
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$9,487 Prepaid expenses andother receivables$3,308 Total current assets$12,795 Total assets$12,795 Accumulated deficit-$25,580,358 Total liabilities andstockholders' equity$12,795 Total stockholders'equity (deficit)-$2,659,714 Additional paid-in capital$22,773,068 Common stock, 0.0001par value,...$147,576 Total currentliabilities$2,672,509 Due to a relatedparty$1,460,077 Convertible loan$1,047,204 Short term loan$120,000 Accounts payable andaccrued liabilities$45,228

CNBX Pharmaceuticals Inc. (CNBX)

CNBX Pharmaceuticals Inc. (CNBX)